NCT06668350 (ASPIRE-II) is a NA clinical trial of Smoking outcomes in Cigarillo Flavor, sponsored by University of Oklahoma.

Who is sponsoring NCT06668350?

NCT06668350 is sponsored by University of Oklahoma.

What drugs are being tested in NCT06668350?

Interventions in NCT06668350: Smoking outcomes.

What condition does NCT06668350 study?

NCT06668350 studies Cigarillo Flavor.

Is NCT06668350 still recruiting?

NCT06668350 is currently recruiting now. Last updated 17 August 2025.

Last reviewed 2025-08-17 · How we verify

NCT06668350: ASPIRE-II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II

Recruiting now NA Last updated 17 August 2025

What this trial tests

NA trial testing Smoking outcomes in Cigarillo Flavor in 190 participants. Currently enrolling.

Timeline

27 June 2025

Primary endpoint
1 February 2029

30 June 2029

Quick facts

Lead sponsor	University of Oklahoma
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	190
Start date	27 June 2025
Primary completion	1 February 2029
Estimated completion	30 June 2029
Sites	1 location across United States

Drugs / interventions tested

Smoking outcomes

Conditions studied

Cigarillo Flavor — all drugs for Cigarillo Flavor →

Sponsor

University of Oklahoma

Who can join

Adults 18 to 34, any sex, with Cigarillo Flavor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multi-method project will recruit young adults who currently use cigarillos and examine the effects of different flavored cigarillo types (concept, characterizing, tobacco) on three measures of tobacco product appeal: subjective effects (e.g., taste, enjoyment, satisfaction, reward), actual smoking behavior (e.g., number of puffs), and tobacco product purchases via a simulated experimental tobacco marketplace.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06668350 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 17 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06668350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing